New Key Statistics Module, Z-Score and F-Score
SZSE:001367 Key Ratios
Market Cap ¥ M | 3,131.92 |
Enterprise Value ¥ M | 2,190.18 |
P/E(ttm) | 26.33 |
PE Ratio without NRI | 25.98 |
Forward PE Ratio | -- |
Price/Book | 2.42 |
Price/Sales | 7.44 |
Price/Free Cash Flow | 37.07 |
Price/Owner Earnings | 25.52 |
Payout Ratio % | 0.42 |
Revenue (TTM) ¥ M | 414.00 |
EPS (TTM) ¥ | 1.17 |
Beneish M-Score | -2.85 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 9.70 |
y-y EBITDA Growth Rate % | -4.60 |
EV-to-EBIT | 16.21 |
EV-to-EBITDA | 16.21 |
PEG | 2.68 |
Shares Outstanding M | 100.64 |
Net Margin (%) | 28.19 |
Operating Margin % | 28.24 |
Pre-tax Margin (%) | 32.53 |
Quick Ratio | 12.63 |
Current Ratio | 14.45 |
ROA % (ttm) | 8.79 |
ROE % (ttm) | 9.41 |
ROIC % (ttm) | 30.36 |
Dividend Yield % | 1.61 |
Altman Z-Score | 18.71 |
SZSE:001367 Number of Guru Trades
SZSE:001367 Volume of Guru Trades
Gurus Latest Trades with SZSE:001367
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:001367 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Haisen Pharmaceutical Co Ltd Insider Transactions
No Available Data